Corindus Vascular Robotics Inc (CVRS) Short Interest Update
Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 11,945,130 shares, an increase of 4.9% from the November 30th total of 11,390,423 shares. Currently, 13.0% of the company’s stock are short sold. Based on an average daily volume of 620,336 shares, the days-to-cover ratio is presently 19.3 days.
Shares of Corindus Vascular Robotics (CVRS) opened at $1.01 on Friday. The stock has a market cap of $188.65, a PE ratio of -4.21 and a beta of 19.51. Corindus Vascular Robotics has a 1-year low of $0.40 and a 1-year high of $2.25.
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last announced its quarterly earnings results on Tuesday, November 7th. The medical equipment provider reported ($0.04) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.01. The firm had revenue of $2.43 million for the quarter, compared to the consensus estimate of $3.60 million. Corindus Vascular Robotics had a negative net margin of 323.84% and a negative return on equity of 110.93%.
CVRS has been the subject of a number of analyst reports. BidaskClub lowered shares of Corindus Vascular Robotics from a “sell” rating to a “strong sell” rating in a research note on Wednesday, October 11th. Zacks Investment Research upgraded shares of Corindus Vascular Robotics from a “hold” rating to a “buy” rating and set a $1.00 price objective for the company in a research note on Monday, November 13th. Finally, ValuEngine lowered shares of Corindus Vascular Robotics from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. Two research analysts have rated the stock with a sell rating and three have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $2.33.
WARNING: “Corindus Vascular Robotics Inc (CVRS) Short Interest Update” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/12/30/corindus-vascular-robotics-inc-cvrs-short-interest-update.html.
About Corindus Vascular Robotics
Corindus Vascular Robotics, Inc is engaged in robotic-assisted vascular interventions. The Company’s CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries.
Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.